Data as of .
FMED vs GXDW: which is really different?
FMED and GXDW hold 0% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: GXDW scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and GXDW hold 0% of their money in the same securities at the same weight.
| Only in FMED | Only in GXDW |
|---|---|
| UCB SA 4.75% | GLOBAL X HYDROGEN ETF 20.93% |
| LIFESTANCE HEALTH GROUP INC 4.29% | GLOBAL X GENOMICS & BIOTECHN 20.55% |
| DANAHER CORP 3.43% | GLOBAL X CYBERSECURITY ETF 20.21% |
| 10X GENOMICS INC 3.12% | GLOBAL X ART INTEL & TECH 19.89% |
| INTUITIVE SURGICAL INC 2.93% | GLOBAL X LITHIUM & BATTERY T 18.41% |
| COGENT BIOSCIENCES INC 2.86% | OTHER PAYABLE & RECEIVABLES 0.01% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | CASH -0.01% |
| ARGENX SE 2.79% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated May 31, 2026 and Sep 18, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | GXDW | FMED | GXDW | FMED | GXDW | |
| 3 months | +21.3% | −13.3% | +19.0 pts | −15.5 pts | +23.7 pts | −10.8 pts |
| 6 months | +32.3% | +10.8% | +14.3 pts | −7.2 pts | +8.0 pts | −13.4 pts |
| 1 year | +28.3% | −10.2% | +11.7 pts | −26.8 pts | +6.5 pts | −32.0 pts |
| 3 years | +39.6% | +3.7% | −38.8 pts | −74.7 pts | −58.5 pts | −94.5 pts |
| Since launch | +25.8% | +2.3% | −57.6 pts | −171.8 pts | −78.1 pts | −273.6 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | GXDW Global X Dorsey Wright Thematic ETF Holds 7 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | Global X |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 0.0% |
| Active share vs the S&P 500 | 97.1% | 100.0% |
| In the Nasdaq-100 | 8.7% | 0.0% |
| Holdings | 68 | 7 |
| Top ten, share of the fund | 31.5% | 100.0% |
| Expense ratio | 0.50% | 0.50% |
| Fee for the differing part | 0.51% | 0.50% |
| Total return, 1 year | +28.3% | −10.2% |
| vs the S&P 500 | +11.7 pts | −26.8 pts |
| vs the Nasdaq-100 | +6.5 pts | −32.0 pts |
| Below its high | −3.8% | −59.4% |
| Net assets | $52m | $6m |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
GXDW in plain words
By weight, 0% of GXDW's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 100% of the fund across 7 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned −10.2% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 26.8 pts. It sits 59.4% below its all-time high of Feb 10, 2021.
Questions people ask
- Do FMED and GXDW hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or GXDW?
- FMED has 25% of its weight in S&P 500 names and GXDW has 0%, so GXDW differs more from the index.
- Which is cheaper, FMED or GXDW?
- FMED charges 0.50% a year and GXDW charges 0.50%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against GXDW, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-gxdw Free to use with attribution; the underlying files are at Open data.